S&P 500   4,171.22 (-0.82%)
DOW   32,801.82 (-0.73%)
QQQ   346.94 (-0.87%)
AAPL   178.69 (+0.78%)
MSFT   328.66 (-0.77%)
META   261.64 (-0.34%)
GOOGL   123.07 (-0.49%)
AMZN   119.21 (-2.01%)
TSLA   196.42 (-2.36%)
NVDA   382.33 (-4.68%)
NIO   7.34 (-0.94%)
BABA   78.20 (-0.60%)
AMD   119.01 (-5.00%)
T   15.83 (+1.21%)
F   12.00 (-4.69%)
MU   68.41 (-4.58%)
CGC   0.81 (-4.85%)
GE   100.47 (-1.88%)
DIS   87.37 (-0.51%)
AMC   4.41 (-4.75%)
PFE   37.66 (+1.76%)
PYPL   61.43 (-1.00%)
NFLX   391.47 (-0.38%)
S&P 500   4,171.22 (-0.82%)
DOW   32,801.82 (-0.73%)
QQQ   346.94 (-0.87%)
AAPL   178.69 (+0.78%)
MSFT   328.66 (-0.77%)
META   261.64 (-0.34%)
GOOGL   123.07 (-0.49%)
AMZN   119.21 (-2.01%)
TSLA   196.42 (-2.36%)
NVDA   382.33 (-4.68%)
NIO   7.34 (-0.94%)
BABA   78.20 (-0.60%)
AMD   119.01 (-5.00%)
T   15.83 (+1.21%)
F   12.00 (-4.69%)
MU   68.41 (-4.58%)
CGC   0.81 (-4.85%)
GE   100.47 (-1.88%)
DIS   87.37 (-0.51%)
AMC   4.41 (-4.75%)
PFE   37.66 (+1.76%)
PYPL   61.43 (-1.00%)
NFLX   391.47 (-0.38%)
S&P 500   4,171.22 (-0.82%)
DOW   32,801.82 (-0.73%)
QQQ   346.94 (-0.87%)
AAPL   178.69 (+0.78%)
MSFT   328.66 (-0.77%)
META   261.64 (-0.34%)
GOOGL   123.07 (-0.49%)
AMZN   119.21 (-2.01%)
TSLA   196.42 (-2.36%)
NVDA   382.33 (-4.68%)
NIO   7.34 (-0.94%)
BABA   78.20 (-0.60%)
AMD   119.01 (-5.00%)
T   15.83 (+1.21%)
F   12.00 (-4.69%)
MU   68.41 (-4.58%)
CGC   0.81 (-4.85%)
GE   100.47 (-1.88%)
DIS   87.37 (-0.51%)
AMC   4.41 (-4.75%)
PFE   37.66 (+1.76%)
PYPL   61.43 (-1.00%)
NFLX   391.47 (-0.38%)
S&P 500   4,171.22 (-0.82%)
DOW   32,801.82 (-0.73%)
QQQ   346.94 (-0.87%)
AAPL   178.69 (+0.78%)
MSFT   328.66 (-0.77%)
META   261.64 (-0.34%)
GOOGL   123.07 (-0.49%)
AMZN   119.21 (-2.01%)
TSLA   196.42 (-2.36%)
NVDA   382.33 (-4.68%)
NIO   7.34 (-0.94%)
BABA   78.20 (-0.60%)
AMD   119.01 (-5.00%)
T   15.83 (+1.21%)
F   12.00 (-4.69%)
MU   68.41 (-4.58%)
CGC   0.81 (-4.85%)
GE   100.47 (-1.88%)
DIS   87.37 (-0.51%)
AMC   4.41 (-4.75%)
PFE   37.66 (+1.76%)
PYPL   61.43 (-1.00%)
NFLX   391.47 (-0.38%)
NASDAQ:SNY

Sanofi (SNY) Stock Forecast, Price & News

$50.57
+0.12 (+0.24%)
(As of 12:27 PM ET)
Compare
Today's Range
$50.40
▼
$50.74
50-Day Range
$50.45
▼
$57.18
52-Week Range
$36.91
▼
$57.82
Volume
509,353 shs
Average Volume
1.89 million shs
Market Capitalization
$127.53 billion
P/E Ratio
18.13
Dividend Yield
2.49%
Price Target
$94.50
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Sanofi MarketRank™ Forecast

Analyst Rating
Hold
2.44 Rating Score
Upside/​Downside
87.4% Upside
$94.50 Price Target
Short Interest
Healthy
0.15% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.98mentions of Sanofi in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.52%
From $4.46 to $4.84 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.49 out of 5 stars

Medical Sector

167th out of 1,006 stocks

Pharmaceutical Preparations Industry

64th out of 492 stocks

See Top Rated MarketRank™ Stocks Here

SNY stock logo

About Sanofi (NASDAQ:SNY) Stock

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Receive SNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.

SNY Stock News Headlines

May 18, 2023 | marketbeat.com
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential (SNY)
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.
May 5, 2023 | marketbeat.com
Regeneron Beats Q1 Views, But Stock Drops On Weak Eye Med Sales (SNY)
Regeneron reported better-than-expected Q1 earnings and revenue, but its Eylea sales fell, losing ground to Roche's newly launched Vabysmo.
May 31, 2023 | Edge On The Street (Ad)
146 Pounds of Graphite Needed for Each EV
Graphite - not lithium - is the largest component of lithium-ion batteries used in electric vehicles. That's why 97 more graphite mines will be needed by 2035 just to keep up with battery demand for the $7 trillion EV market.
May 31, 2023 | markets.businessinsider.com
Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis
May 30, 2023 | americanbankingnews.com
Brokerages Set Sanofi (NASDAQ:SNY) PT at $93.50
May 28, 2023 | americanbankingnews.com
Sanofi (NASDAQ:SNY) Declares $1.38 Annual Dividend
May 22, 2023 | finance.yahoo.com
2 Bear Market Defying Stocks to Buy in May
May 19, 2023 | msn.com
Sobi's hemophilia A therapy gets review in EU
May 31, 2023 | Edge On The Street (Ad)
The Ignored EV Story Few Investors Know About
Lithium may grab all the headlines, but the average electric vehicle requires 146 pounds of the mineral graphite. With no producing graphite mines in North America, the U.S. government is desperate for more domestic sources of the metal to feed the EV battery supply chain.
May 19, 2023 | msn.com
Amgen (NASDAQ:AMGN) Loses Patent Battle to Sanofi, Regeneron
May 18, 2023 | seekingalpha.com
Supreme Court rules against Amgen in Rapatha patent dispute with Sanofi/ Regeneron
May 18, 2023 | investing.com
U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents
May 18, 2023 | msn.com
Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron
May 18, 2023 | finance.yahoo.com
Sanofi Applauds Supreme Court Ruling Supporting Scientific Innovation by Striking Down Amgen's Asserted PCSK9 Patent Claims in Amgen v Sanofi
May 16, 2023 | thestreet.com
Buy Warren Buffett's 5 Highest-Yielding Dividend Stocks for Income Now
May 16, 2023 | americanbankingnews.com
Sanofi (NYSE:SNY) Downgraded by StockNews.com
May 15, 2023 | benzinga.com
Peering Into Sanofi's Recent Short Interest
May 13, 2023 | realmoney.thestreet.com
These 3 Global Drug Stocks Have a Prescription for High Yields
May 13, 2023 | americanbankingnews.com
Sanofi (NYSE:SNY) Downgraded to Buy at StockNews.com
May 12, 2023 | msn.com
Rebates or Patent Abuse? Eli Lilly, Novo Nordisk, and Sanofi CEOs Cross Swords with PBMs in Senate Hearing
May 12, 2023 | americanbankingnews.com
Head to Head Analysis: TherapeuticsMD (NASDAQ:TXMD) and Sanofi (NASDAQ:SNY)
May 5, 2023 | americanbankingnews.com
Sanofi (NASDAQ:SNY) Receives $100.20 Consensus Price Target from Analysts
May 3, 2023 | americanbankingnews.com
Q2 2023 EPS Estimates for Sanofi (NASDAQ:SNY) Lowered by SVB Leerink
May 1, 2023 | finance.yahoo.com
Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront
April 29, 2023 | americanbankingnews.com
Sanofi (NASDAQ:SNY) Downgraded by Deutsche Bank Aktiengesellschaft to Sell
April 28, 2023 | finance.yahoo.com
Sanofi (SNY) Q1 2023 Earnings Call Transcript
April 27, 2023 | finance.yahoo.com
Sanofi Posts Upbeat Q1 Earnings, Sales Buoyed By Blockbuster Dupixent Sales
See More Headlines
Receive SNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.

SNY Company Calendar

Last Earnings
4/27/2023
Ex-Dividend for 6/23 Dividend
5/30/2023
Today
5/31/2023
Dividend Payable
6/23/2023
Next Earnings (Estimated)
7/27/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SNY
CUSIP
N/A
CIK
1121404
Web
www.sanofi.com
Phone
(315) 377-4000
Fax
33-1-53-77-43-03
Employees
91,573
Year Founded
2004

Price Target and Rating

Average Stock Price Forecast
$94.50
High Stock Price Forecast
$119.00
Low Stock Price Forecast
$60.00
Forecasted Upside/Downside
+87.4%
Consensus Rating
Hold
Rating Score (0-4)
2.44
Research Coverage
9 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$2.79
Trailing P/E Ratio
18.08
Forward P/E Ratio
11.31
P/E Growth
1.72
Net Income
$8.82 billion
Net Margins
15.41%
Pretax Margin
24.33%
Return on Equity
28.45%
Return on Assets
16.76%

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
1.42
Quick Ratio
1.05

Sales & Book Value

Annual Sales
$45.31 billion
Price / Sales
2.81
Cash Flow
$5.52 per share
Price / Cash Flow
9.13
Book Value
$31.40 per share
Price / Book
1.61

Miscellaneous

Outstanding Shares
2,521,930,000
Free Float
2,496,708,000
Market Cap
$127.21 billion
Optionable
Optionable
Beta
0.57

Social Links


Key Executives

  • Paul HudsonPaul Hudson
    Chief Executive Officer & Director
  • Jean-Baptiste Chasseloup de ChatillonJean-Baptiste Chasseloup de Chatillon
    Chief Financial Officer & Executive Vice President
  • Nestle Frank
    Global Head-Immunology Therapeutic Research Area
  • Dietmar P. Berger
    Chief Medical Officer & Global Head-Development
  • Natalie Bickford
    Chief People Officer & Executive Vice President

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













SNY Stock - Frequently Asked Questions

Should I buy or sell Sanofi stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SNY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNY, but not buy additional shares or sell existing shares.
View SNY analyst ratings or view top-rated stocks.

What is Sanofi's stock price forecast for 2023?

9 Wall Street research analysts have issued 12-month price objectives for Sanofi's shares. Their SNY share price forecasts range from $60.00 to $119.00. On average, they expect the company's stock price to reach $94.50 in the next year. This suggests a possible upside of 87.3% from the stock's current price.
View analysts price targets for SNY or view top-rated stocks among Wall Street analysts.

How have SNY shares performed in 2023?

Sanofi's stock was trading at $48.43 at the beginning of 2023. Since then, SNY stock has increased by 4.2% and is now trading at $50.45.
View the best growth stocks for 2023 here.

When is Sanofi's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our SNY earnings forecast.

How were Sanofi's earnings last quarter?

Sanofi (NASDAQ:SNY) issued its quarterly earnings data on Thursday, April, 27th. The company reported $1.16 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.06. The business had revenue of $10.97 billion for the quarter, compared to analysts' expectations of $11.60 billion. Sanofi had a net margin of 15.41% and a trailing twelve-month return on equity of 28.45%.

How often does Sanofi pay dividends? What is the dividend yield for Sanofi?

Sanofi declared an annual dividend on Tuesday, May 30th. Investors of record on Wednesday, May 31st will be given a dividend of $1.377 per share on Friday, June 23rd. This represents a dividend yield of 2.94%. The ex-dividend date of this dividend is Tuesday, May 30th.
Read our dividend analysis for SNY.

What ETFs hold Sanofi's stock?

ETFs with the largest weight of Sanofi (NASDAQ:SNY) stock in their portfolio include Pacer BioThreat Strategy ETF (VIRS), VanEck Pharmaceutical ETF (PPH), Subversive Mental Health ETF (SANE), Simplify Health Care ETF (PINK), Horizon Kinetics Medical ETF (MEDX), Invesco International Dividend Achievers ETF (PID), Putnam Focused Large Cap Value ETF (PVAL) and Amplify International Enhanced Dividend Income ETF (IDVO).

Is Sanofi a good dividend stock?

Sanofi (NASDAQ:SNY) pays an annual dividend of $1.26 per share and currently has a dividend yield of 2.40%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 45.16%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SNY will have a dividend payout ratio of 26.03% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SNY.

What is Paul Hudson's approval rating as Sanofi's CEO?

277 employees have rated Sanofi Chief Executive Officer Paul Hudson on Glassdoor.com. Paul Hudson has an approval rating of 94% among the company's employees. This puts Paul Hudson in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Sanofi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include AbbVie (ABBV), Abbott Laboratories (ABT), Adobe (ADBE), Amgen (AMGN), Broadcom (AVGO), Boeing (BA), Alibaba Group (BABA), Bank of America (BAC) and BP (BP).

What is Sanofi's stock symbol?

Sanofi trades on the NASDAQ under the ticker symbol "SNY."

Who are Sanofi's major shareholders?

Sanofi's stock is owned by a variety of retail and institutional investors. Top institutional investors include Dodge & Cox (3.27%), FMR LLC (0.92%), Boston Partners (0.71%), Fisher Asset Management LLC (0.53%), Bank of America Corp DE (0.42%) and BlackRock Inc. (0.40%).
View institutional ownership trends.

How do I buy shares of Sanofi?

Shares of SNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sanofi's stock price today?

One share of SNY stock can currently be purchased for approximately $50.45.

How much money does Sanofi make?

Sanofi (NASDAQ:SNY) has a market capitalization of $127.23 billion and generates $45.31 billion in revenue each year. The company earns $8.82 billion in net income (profit) each year or $2.79 on an earnings per share basis.

How many employees does Sanofi have?

The company employs 91,573 workers across the globe.

Does Sanofi have any subsidiaries?
The following companies are subsidiares of Sanofi: A. Nattermann & Cie. GmbH, AO Sanofi Russia, Ablynx, Ablynx N.V., Allston Landing Limited Partnership, Aventis Inc., Aventis Pharma (Manufacturing) Pte. Ltd, Aventis Pharma Limited, Aventis Pharma S.A., Aventis S.A., Aventisub LLC, Bioverativ, Bioverativ Inc., Bioverativ Therapeutics Inc., Bioverativ U.S.LLC, Carraig Insurance DAC, Chattem Inc., Chinoin Private Co. Ltd, Francopia, Genfar S.A., Genzyme Corporation, Genzyme Europe B.V., Genzyme Flanders BVBA, Genzyme Global Sarl, Genzyme Ireland Limited, Genzyme Limited, Genzyme Polyclonals SAS, Genzyme Therapeutic Products Limited Partnership, Genzyme Therapeutics Limited, Genzyme de Argentina S.A., Hoechst GmbH, Kiadis Pharma, Limited Liability Company Sanofi-Aventis Ukraine, PT Aventis Pharma, Principia BioPharma, SSP Co. Ltd, Sanofi (Beijing) Pharmaceuticals Co.Ltd, Sanofi (China) Investment Co. Ltd, Sanofi (Hangzhou) Pharmaceuticals Co. Ltd, Sanofi A/S, Sanofi AB, Sanofi Arabia Trading Company Limited, Sanofi Aventis NA Holding Inc., Sanofi Belgium, Sanofi Biotechnology, Sanofi Chimie, Sanofi Egypt, Sanofi Finance Ireland limited, Sanofi Foreign Participations B.V., Sanofi Healthcare India Private Limited, Sanofi Ilac Sanayi ve Ticaret A.S., Sanofi India Limited, Sanofi K.K., Sanofi Mature IP, Sanofi Medley Farmaceutica Ltda, Sanofi Nichi-Iko K.K., Sanofi Oy, Sanofi Pasteur, Sanofi Pasteur Asi Ticaret A.S., Sanofi Pasteur Biologies Co. Ltd, Sanofi Pasteur Europe, Sanofi Pasteur Inc., Sanofi Pasteur India Private Ltd, Sanofi Pasteur Limited, Sanofi Pasteur Ltd, Sanofi Pasteur NVL, Sanofi Pasteur S.A. de C.V., Sanofi Produtos Farmaceuticos Lda, Sanofi Romania SRL, Sanofi S.p.A., Sanofi Saglik Urunleri Limited Sirketi, Sanofi Taiwan Co. Ltd, Sanofi US Corporation, Sanofi US Services Inc., Sanofi Vaccine Technologies, Sanofi Winthrop Industrie, Sanofi-Aventis (Malaysia) SDN. BHD., Sanofi-Aventis (Suisse) SA, Sanofi-Aventis (Thailand) Ltd, Sanofi-Aventis A.E.B.E., Sanofi-Aventis Algérie, Sanofi-Aventis Argentina S.A., Sanofi-Aventis Australia Pty Ltd, Sanofi-Aventis Canada Inc., Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis France, Sanofi-Aventis GmbH, Sanofi-Aventis Groupe, Sanofi-Aventis Gulf FZE, Sanofi-Aventis Healthcare Pty Ltd, Sanofi-Aventis Hong-Kong Limited, Sanofi-Aventis Ireland Ltd, Sanofi-Aventis Israël Ltd, Sanofi-Aventis Korea Co. Ltd, Sanofi-Aventis Liban s.a.l., Sanofi-Aventis Maroc, Sanofi-Aventis Netherlands B.V., Sanofi-Aventis Norge AS, Sanofi-Aventis Pakistan Limited, Sanofi-Aventis Participations, Sanofi-Aventis Philippines Inc., Sanofi-Aventis Private Co Ltd, Sanofi-Aventis Recherche & Développement, Sanofi-Aventis S.A., Sanofi-Aventis Singapore Pte. Ltd, Sanofi-Aventis South Africa (Pty) Ltd, Sanofi-Aventis Sp. z.o.o., Sanofi-Aventis U.S. LLC, Sanofi-Aventis UK Holdings Limited, Sanofi-Aventis Winthrop S.A. de C.V., Sanofi-Aventis de Colombia S.A., Sanofi-Aventis de Mexico S.A. de C.V., Sanofi-Aventis de Panama S.A., Sanofi-Aventis de Venezuela S.A., Sanofi-Aventis del Ecuador S.A., Sanofi-Aventis del Peru S.A., Sanofi-Aventis s.r.o., Sanofi-Synthelabo (India) Private Ltd, Sanofi-aventis Vietnam Company Limited, Shenzhen Sanofi pasteur Biological Products Co Ltd, Synthorx, VaxServe Inc., sanofi-aventis Puerto Rico Inc, and sanofi-aventis Slovakia s.r.o..
Read More
How can I contact Sanofi?

Sanofi's mailing address is 54 RUE LA BOETIE, PARIS I0, 75008. The official website for the company is www.sanofi.com. The company can be reached via phone at (315) 377-4000, via email at ir@sanofi.com, or via fax at 33-1-53-77-43-03.

This page (NASDAQ:SNY) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -